JBSS Stock Analysis: John Sanfilippo & Son | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 1.013m USD | 12M Return: 36.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 9.03M
EPS Trend: 54.8%
Qual. Beats: 0
Rev. Trend: 94.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) is a U.S.-based processor and distributor of tree nuts and peanuts, operating primarily through its subsidiary JBSS Ventures, LLC. The company offers an extensive product portfolio that includes raw and processed nuts (almonds, pecans, peanuts, walnuts, cashews, pistachios, and others), nutrition and snack bars, peanut butter, dried fruit, snack mixes, and toppings for ice cream and yogurt, among other items. JBSS markets its products under proprietary brands such as Fisher, Orchard Valley Harvest, Squirrel Brand, Southern Style Nuts, and Just the Cheese, as well as under various private-label brands. Its customer base spans retailers, wholesalers, and commercial ingredient and contract packaging clients, served through independent brokers, distributors, and suppliers. Founded in 1922 and headquartered in Elgin, Illinois, the company is publicly traded on NASDAQ and operates within the Consumer Staples sectors Packaged Foods & Meats sub-industry. As a packaged foods producer, JBSS benefits from the typically defensive characteristics of the consumer staples sector, with demand that tends to be relatively stable through economic cycles, and it generates revenue through both branded consumer products and B2B ingredient and contract packaging services.
- Tree nut commodity prices pressure product gross margins
- Private label nut sales expand with key retailer partnerships
- Fisher and Orchard Valley Harvest branded revenue grows
| Net Income: 67.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 10.70 > 1.0 |
| NWC/Revenue: 17.09% < 20% (prev 15.82%; Δ 1.27% < -1%) |
| CFO/TA 0.20 > 3% & CFO 131.4m > Net Income 67.1m |
| Net Debt (119.0m) to EBITDA (126.4m): 0.94 < 3 |
| Current Ratio: 2.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.8m) vs 12m ago 0.53% < -2% |
| Gross Margin: 18.54% > 18% (prev 18.48%; Δ 0.06% > 0.5%) |
| Asset Turnover: 187.7% > 50% (prev 187.8%; Δ -0.07% > 0%) |
| Interest Coverage Ratio: 28.96 > 6 (EBIT TTM 93.2m / Interest Expense TTM 3.22m) |
| A: 0.31 (Total Current Assets 352.1m - Total Current Liabilities 153.2m) / Total Assets 650.7m |
| B: 0.38 (Retained Earnings 245.8m / Total Assets 650.7m) |
| C: 0.15 (EBIT TTM 93.2m / Avg Total Assets 620.3m) |
| D: 1.47 (Book Value of Equity 387.6m / Total Liabilities 263.0m) |
| Altman-Z'' = 5.79 = AAA |
| DSRI: 1.09 (Receivables 85.2m/74.5m, Revenue 1.16b/1.11b) |
| GMI: 1.00 (GM 18.48% / 18.54%) |
| AQI: 0.67 (AQ_t 0.06 / AQ_t-1 0.09) |
| SGI: 1.05 (Revenue 1.16b / 1.11b) |
| TATA: -0.10 (NI 67.1m - CFO 131.4m) / TA 650.7m) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of July 13, 2026, the stock is trading at USD 87.17 with a total of 137,979 shares traded. Over the past week, the price has changed by -3.79%, over one month by +9.74%, over three months by +10.13% and over the past year by +36.52%.
Current recommended Stop Loss: 81.60 (which is 6.4% or 2.3 ATR below the current price).
John Sanfilippo & Son has no consensus analysts rating.
| Analysts Target Price | 102 | 17% |
P/E Trailing = 15.1786
P/E Forward = 13.7931
P/S = 0.8702
P/B = 2.7287
P/EG = 1.5178
Revenue TTM = 1.16b USD
EBIT TTM = 93.2m USD
EBITDA TTM = 126.4m USD
Long Term Debt = 40.7m USD (from longTermDebt, last quarter)
Short Term Debt = 35.7m USD (from shortTermDebt, last quarter)
Debt = 120.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 21.9m
Net Debt = 119.0m USD (calculated: Debt 120.2m - CCE 1.29m)
Enterprise Value = 1.13b USD (1.01b + Debt 120.2m - CCE 1.29m)
Interest Coverage Ratio = 28.96 (Ebit TTM 93.2m / Interest Expense TTM 3.22m)
EV/FCF = 23.16x (Enterprise Value 1.13b / FCF TTM 48.9m)
FCF Yield = 4.32% (FCF TTM 48.9m / Enterprise Value 1.13b)
FCF Margin = 4.20% (FCF TTM 48.9m / Revenue TTM 1.16b)
Net Margin = 5.76% (Net Income TTM 67.1m / Revenue TTM 1.16b)
Gross Margin = 18.54% ((Revenue TTM 1.16b - Cost of Revenue TTM 948.5m) / Revenue TTM)
Gross Margin QoQ = 19.08% (prev 18.80%)
Tobins Q-Ratio = 1.74 (Enterprise Value 1.13b / Total Assets 650.7m)
Interest Expense / Debt = 2.68% (Interest Expense 3.22m / Debt 120.2m)
Taxrate = 25.48% (22.9m / 90.0m)
NOPAT = 69.5m (EBIT 93.2m * (1 - 25.48%))
Current Ratio = 2.30 (Total Current Assets 352.1m / Total Current Liabilities 153.2m)
Debt / Equity = 0.31 (Debt 120.2m / totalStockholderEquity, last quarter 387.6m)
Debt / EBITDA = 0.94 (Net Debt 119.0m / EBITDA 126.4m)
Debt / FCF = 2.43 (Net Debt 119.0m / FCF TTM 48.9m)
Total Stockholder Equity = 370.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.81% (Net Income 67.1m / Total Assets 650.7m)
RoE = 18.11% (Net Income TTM 67.1m / Total Stockholder Equity 370.3m)
RoCE = 22.68% (EBIT 93.2m / Capital Employed (Equity 370.3m + L.T.Debt 40.7m))
RoIC = 13.06% (NOPAT 69.5m / Invested Capital 531.9m)
WACC = 5.44% (E(1.01b)/V(1.13b) * Re(5.85%) + D(120.2m)/V(1.13b) * Rd(2.68%) * (1-Tc(0.25)))
Discount Rate = 5.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.21 | Cagr: 0.50%
[DCF] Terminal Value 75.44% ; FCFF base≈48.9m ; Y1≈49.1m ; Y5≈52.0m
[DCF] Fair Price = 75.86 (EV 808.7m - Net Debt 119.0m = Equity 689.7m / Shares 9.09m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 54.83 | EPS CAGR: 8.89% | SUE: 0.51 | # QB: 0
Revenue Correlation: 94.62 | Revenue CAGR: 6.34% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.62 | Chg30d=-13.47% | Revisions=-25% | Analysts=2
EPS current Year (2026-06-30): EPS=5.73 | Chg30d=-2.16% | Revisions=+25% | GrowthEPS=+13.9% | GrowthRev=+0.0%
EPS next Year (2027-06-30): EPS=6.05 | Chg30d=-7.81% | Revisions=-25% | GrowthEPS=+5.7% | GrowthRev=+1.8%
[Analyst] Revisions Ratio: -17% (up=1, down=2)